These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37480722)

  • 1. Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy.
    Stack JP; Fries RC; Kruckman L; Kadotani S; Wallace G
    J Vet Cardiol; 2023 Aug; 48():54-62. PubMed ID: 37480722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy.
    Karabinowska-Małocha A; Dziewięcka E; Szymańska M; Banyś P; Urbańczyk-Zawadzka M; Krupiński M; Mielnik M; Wiśniowska-Śmiałek S; Podolec P; Budkiewicz A; Żydzik Ł; Wypasek E; Rubiś P
    Kardiol Pol; 2023; 81(7-8):692-699. PubMed ID: 37431248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.
    Seo J; Payne JR; Novo Matos J; Fong WW; Connolly DJ; Luis Fuentes V
    J Vet Intern Med; 2020 Sep; 34(5):1718-1727. PubMed ID: 32822105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy.
    Fries RC; Kadotani S; Keating SCJ; Stack JP
    J Vet Intern Med; 2021 Mar; 35(2):812-822. PubMed ID: 33634479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
    Gawor M; Śpiewak M; Kubik A; Wróbel A; Lutyńska A; Marczak M; Grzybowski J
    Biomarkers; 2018 Nov; 23(7):676-682. PubMed ID: 29737871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
    Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
    J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.
    Borgeat K; Sherwood K; Payne JR; Luis Fuentes V; Connolly DJ
    J Vet Intern Med; 2014; 28(6):1731-7. PubMed ID: 25319115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic Cardiomyopathy-Advances in Imaging and Diagnostic Strategies.
    Fries R
    Vet Clin North Am Small Anim Pract; 2023 Nov; 53(6):1325-1342. PubMed ID: 37423845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy.
    Hori Y; Iguchi M; Heishima Y; Yamashita Y; Nakamura K; Hirakawa A; Kitade A; Ibaragi T; Katagi M; Sawada T; Yuki M; Kanno N; Inaba H; Isayama N; Onodera H; Iwasa N; Kino M; Narukawa M; Uchida S
    J Vet Intern Med; 2018 May; 32(3):922-929. PubMed ID: 29660794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac biomarkers in hyperthyroid cats.
    Sangster JK; Panciera DL; Abbott JA; Zimmerman KC; Lantis AC
    J Vet Intern Med; 2014; 28(2):465-72. PubMed ID: 24350989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
    Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy.
    Hanås S; Larsson A; Rydén J; Lilliehöök I; Häggström J; Tidholm A; Höglund K; Ljungvall I; Holst BS
    J Feline Med Surg; 2022 Oct; 24(10):e370-e379. PubMed ID: 36073987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L; Kilkenny E; Ferasin H
    J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy.
    Rohrbaugh MN; Schober KE; Rhinehart JD; Bonagura JD; Habing A; Yildiz V
    J Vet Intern Med; 2020 May; 34(3):1091-1101. PubMed ID: 32364632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
    Hsu A; Kittleson MD; Paling A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function.
    Yakar Tülüce S; Tülüce K; Çil Z; Emren SV; Akyıldız Zİ; Ergene O
    Anatol J Cardiol; 2016 May; 16(5):344-8. PubMed ID: 26488381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.
    Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M
    Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.